Effect of tourniquet use on activation of coagulation in total knee replacement
- PMID: 10693564
- DOI: 10.1097/00003086-200002000-00021
Effect of tourniquet use on activation of coagulation in total knee replacement
Abstract
Total knee replacement often is performed with tourniquet application. The advantages of a dry field, including fixation, are well known, but it still is debatable if tourniquet application increases deep vein thrombosis. Measurement of coagulation markers is a well accepted method of studying thrombogenesis activation intraoperatively and postoperatively. Twenty patients undergoing total knee replacement with subarachnoid anesthesia were assigned randomly to two groups: either with tourniquet application (Group I) or without tourniquet application (Group II). There were no differences between patients in the two groups in terms of age, gender, diagnosis (all had osteoarthritis), operative time, and total (intraoperative and postoperative) blood loss. Markers for thrombin generation and fibrinolysis were measured. Blood samples were drawn at four times: baseline before the operation; after bone cuts; after cement fixation (Group II) or 2 minutes after tourniquet deflation (Group I); and 1 hour after surgery. Markers of thrombin generation and fibrinolysis showed a significant increase from baseline in all the patients. In Group II these markers started to increase during surgery, whereas in Group I the increase occurred at the end of the procedure when the tourniquet was deflated. The total amount of thrombin generation was significantly higher in Group II (without tourniquet), whereas fibrinolysis was significantly greater in Group I. Total knee replacement is accompanied by a hypercoagulative state with or without the use of a tourniquet, but it seems to be higher when the tourniquet is not used. In addition, tourniquet application may increase fibrinolysis.
Similar articles
-
Changes in circulatory indices of thrombosis and fibrinolysis during total knee arthroplasty performed under tourniquet.J Arthroplasty. 1995 Aug;10(4):523-8. doi: 10.1016/s0883-5403(05)80155-x. J Arthroplasty. 1995. PMID: 8523013
-
Time course of thrombosis and fibrinolysis in total knee arthroplasty with tourniquet application. Local versus systemic activations.J Thromb Thrombolysis. 2009 Nov;28(4):425-8. doi: 10.1007/s11239-008-0299-6. Epub 2008 Dec 6. J Thromb Thrombolysis. 2009. PMID: 19067121
-
The effect of tourniquet application, tranexamic acid, and desmopressin on the procoagulant and fibrinolytic systems during total knee replacement.J Clin Anesth. 2001 Nov;13(7):509-13. doi: 10.1016/s0952-8180(01)00319-1. J Clin Anesth. 2001. PMID: 11704449 Clinical Trial.
-
Timing of Tourniquet Release in Total Knee Arthroplasty.Orthopedics. 2015 Jul 1;38(7):445-51. doi: 10.3928/01477447-20150701-06. Orthopedics. 2015. PMID: 26186313 Review.
-
Timing of tourniquet release in knee arthroplasty. Meta-analysis of randomized, controlled trials.J Bone Joint Surg Am. 2007 Apr;89(4):699-705. doi: 10.2106/JBJS.F.00497. J Bone Joint Surg Am. 2007. PMID: 17403789 Review.
Cited by
-
Does limb preconditioning reduce pain after total knee arthroplasty? A randomized, double-blind study.Clin Orthop Relat Res. 2014 May;472(5):1467-74. doi: 10.1007/s11999-013-3106-4. Clin Orthop Relat Res. 2014. PMID: 23761178 Free PMC article. Clinical Trial.
-
Association of Use of Tourniquets During Total Knee Arthroplasty in the Elderly Patients With Post-operative Pain and Return to Function.Front Public Health. 2022 Mar 10;10:825408. doi: 10.3389/fpubh.2022.825408. eCollection 2022. Front Public Health. 2022. PMID: 35359779 Free PMC article.
-
The efficacy of tourniquet assisted total knee arthroplasty on patient-reported and performance-based physical function: a randomized controlled trial protocol.BMC Musculoskelet Disord. 2014 Mar 29;15:110. doi: 10.1186/1471-2474-15-110. BMC Musculoskelet Disord. 2014. PMID: 24678741 Free PMC article.
-
Potential Risk Factors Contributing to Development of Venous Thromboembolism for Total Knee Replacements Patients Prophylaxed With Rivaroxaban: A Retrospective Case-Control Study.Clin Appl Thromb Hemost. 2020 Jan-Dec;26:1076029620962226. doi: 10.1177/1076029620962226. Clin Appl Thromb Hemost. 2020. PMID: 33064561 Free PMC article.
-
Serum D-dimer should not be used in the diagnosis of venous thromboembolism within 28 days of total knee replacement surgery.Knee Surg Relat Res. 2020 Sep 22;32(1):49. doi: 10.1186/s43019-020-00068-x. Knee Surg Relat Res. 2020. PMID: 32962751 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical